Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials.
about
Clozapine: a review of clinical practice guidelines and prescribing trendsAmphetamine-induced psychosis--a separate diagnostic entity or primary psychosis triggered in the vulnerable?Risperidone (depot) for schizophreniaAntipsychotic medications for cocaine dependenceAntiglucocorticoid and related treatments for psychosisHaloperidol dose for the acute phase of schizophreniaAntipsychotic combinations for schizophreniaOlanzapine depot for schizophreniaTreatment for amphetamine psychosisAntiglucocorticoid and related treatments for psychosisAntipsychotic medications for cocaine dependenceLithium for schizophreniaGlutamatergic drugs for schizophreniaDepot risperidone for schizophreniaSertindole in the management of schizophreniaAtypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysisRecognition and Management of Behavioral Disturbances in DementiaThe use of amisulpride in the treatment of acute psychosisSex and laterality differences in parkinsonian impairment and transcranial ultrasound in never-treated schizophrenics and their first degree relatives in an Andean populationDevelopment of a Web-Based Clinical Decision Support System for Drug Prescription: Non-Interventional Naturalistic Description of the Antipsychotic Prescription Patterns in 4345 Outpatients and Future ApplicationscDNA array reveals increased expression of glucose-dependent insulinotropic polypeptide following chronic clozapine treatment: role in atypical antipsychotic drug-induced adverse metabolic effectsDetection, Assessment, and Management of Schizophrenia in an Andean Population of South America: Parkinsonism Testing and Transcranial Ultrasound as Preventive Tools.Antipsychotic drugs on maternal behavior in rats.Effectiveness of antipsychotics used in first-episode psychosis: a naturalistic cohort study.Novel antipsychotics: issues and controversies. Typicality of atypical antipsychotics.Relationships between pharmacotherapy-induced metabolic changes and improved psychopathology in schizophrenia: data from a mirtazapine and first-generation antipsychotics combination trial.Haloperidol dose for the acute phase of schizophrenia.Selection of atypical antipsychotics for the management of schizophrenia.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia.Association of the PPAR-γ Gene with Altered Glucose Levels and Psychosis Profile in Schizophrenia Patients Exposed to Antipsychotics.Long-acting paliperidone palmitate - interim results of an observational study of its effect on hospitalization.Fortnightly review. Treatment of schizophrenia.Effectiveness evaluation of a pharmacist-driven monitoring database for tardive dyskinesia.Modern antipsychotic drugs: a critical overviewMeasuring neuropsychological change in schizophrenia with novel antipsychotic medicationsAssessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study resultsImproving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. QUOROM Group.A systematic review of meta-analyses of the efficacy of oral atypical antipsychotics for the treatment of adult patients with schizophrenia.Reasoning about the optimal duration of prophylactic antipsychotic medication in schizophrenia: evidence and arguments.Olanzapine: another psychotropic?
P2860
Q21260307-5592D2C9-EC56-4212-BB64-29B170181332Q21260315-B2D0E31F-7A2C-41FD-B474-13F9CDDD6440Q24185901-ECE35BA8-BAB0-4753-9B14-EA10EC764FA0Q24186021-18DEF286-0E1C-4B51-A88B-8D6269E15CEAQ24186594-8E080C2C-ECC7-435E-A568-1ABCCD634575Q24200200-79400242-2DF7-4238-BC2D-137CA2FC1956Q24234513-644A59BC-7979-49C3-93AF-4A868E6AD090Q24240925-6F255514-4863-4201-9D71-2B9DC9485444Q24241011-F08092F1-7640-4CA1-A15A-4850AE01FB52Q24243495-DB5F5CF2-F4F9-4547-A77B-9A69FAC6D9E9Q24243837-9B918A3A-44D5-4CD0-95D2-F67B9CD1B7A8Q24244034-FD1BA68B-0B79-4A04-99E2-46006C8CBB80Q24246163-C38EC696-9F98-4AE8-AC84-BC7DD614CE33Q24247787-C2E0B54D-F543-4F8C-BD65-C366F867A9F9Q24621369-839B6CC8-92D9-48CE-8564-A8CFF670DFDBQ24645193-6DC408BF-ED3C-4CD6-8CDC-3851D0846942Q24682986-011A1335-6499-4F8D-BE0D-DA37C5D77AF4Q24683055-093801D5-1717-4996-9DAB-5D96C0BDB518Q27303919-D290F65B-78D6-41EF-BE1C-EAD5687F57B2Q28552825-71E2EC25-6260-440B-86A3-DC1C412E3671Q28574297-9E9ADD97-1A9B-4AFB-A49F-6B05B858C03FQ30373174-BECB9FCA-69DD-45F7-A840-7AF5A0C095E8Q30375083-0B646EA6-E9C9-4889-9A94-122226A5F84EQ30490166-8C8E055B-AE58-4988-9475-3704F28E786FQ30501297-D651D6B0-0377-4969-A214-841DB981D9E8Q30580432-B76FE610-BEAF-409E-AC6E-11AAD61AC544Q30838771-309D1142-C3E5-4C34-A870-85A9E57A697FQ31037993-7D5189B0-DEF0-493F-915A-AE63460C1BC0Q33223628-73E5B1DF-54D8-4C1B-83C8-565E9BADB2FAQ33620389-633FF94B-7EF8-4A62-8D78-0F5EF5513FB8Q33718170-5C7BABDF-A7DC-4CFC-BF89-C51480BA4D1EQ33751787-842002C6-B087-4A48-854D-BB73E7ADE21BQ33774764-F86D444F-2BBE-48F9-A0AD-68367B231412Q33853390-199A1EA9-C278-4837-9149-4F53316A20E7Q33877837-7E2B0DF6-406E-41C7-9F3B-B5E0A9580B75Q34048194-4200747E-2686-4158-B2B3-02BD2CF35578Q34089161-C3868470-3DF9-490A-9A9D-3C665367C9EAQ34224372-3FDA85E5-7955-4B89-9E5B-EB442C865006Q34266206-F8EE4592-32C1-4518-B39E-38FCA89555FCQ34283153-2BB63664-735E-4CD5-90F9-4436F515A427
P2860
Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Efficacy and extrapyramidal si ...... randomized controlled trials.
@en
type
label
Efficacy and extrapyramidal si ...... randomized controlled trials.
@en
prefLabel
Efficacy and extrapyramidal si ...... randomized controlled trials.
@en
P2093
P1476
Efficacy and extrapyramidal si ...... randomized controlled trials.
@en
P2093
G Pitschel-Walz
P356
10.1016/S0920-9964(98)00105-4
P407
P577
1999-01-01T00:00:00Z